Priya Sachdeva

Stock Analyst at UBS

(2.30)

# 2,697

Out of 5,102 analysts

5

Total ratings

60%

Success rate

9.92%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$330 → $335	$311.40	+7.58%	4	Jul 30, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$16.48	+3.16%	1	Jan 21, 2025

Penumbra

Jul 30, 2025

Maintains: Buy

Price Target: $330 → $335

Current: $311.40

Upside: +7.58%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $16.48

Upside: +3.16%